226 related articles for article (PubMed ID: 2900820)
1. Peptide conformation. 48. Conformation and biological activity of proline containing cyclic retro-analogues of somatostatin.
Kessler H; Klein M; Wagner K
Int J Pept Protein Res; 1988 May; 31(5):481-98. PubMed ID: 2900820
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationship studies optimizing the antiproliferative activity of novel cyclic somatostatin analogues containing a restrained cyclic beta-amino acid.
Sukopp M; Schwab R; Marinelli L; Biron E; Heller M; Várkondi E; Pap A; Novellino E; Kéri G; Kessler H
J Med Chem; 2005 Apr; 48(8):2916-26. PubMed ID: 15828830
[TBL] [Abstract][Full Text] [Related]
3. The pseudo-beta I-turn. A new structural motif with a cis peptide bond in cyclic hexapeptides.
Kessler H; Matter H; Gemmecker G; Diehl HJ; Isernia C; Mronga S
Int J Pept Protein Res; 1994 Jan; 43(1):47-61. PubMed ID: 8138351
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, biological activity and conformational study of a somatostatin hexapeptide analogue containing a reduced peptide bond.
Delaet NG; Verheyden P; Velkeniers B; Hooghe-Peters EL; Bruns C; Tourwé D; Van Binst G
Pept Res; 1993; 6(1):24-30. PubMed ID: 8094990
[TBL] [Abstract][Full Text] [Related]
5. Peptide conformations--49(1): synthesis and structure-activity relationships of side chain modified peptides of cyclo(-D-Pro-Phe-Thr-Lys-Trp-Phe.).
Kessler H; Haupt A; Schudok M; Ziegler K; Frimmer M
Int J Pept Protein Res; 1988 Sep; 32(3):183-93. PubMed ID: 2907513
[TBL] [Abstract][Full Text] [Related]
6. Novel sst(4)-selective somatostatin (SRIF) agonists. 4. Three-dimensional consensus structure by NMR.
Grace CR; Koerber SC; Erchegyi J; Reubi JC; Rivier J; Riek R
J Med Chem; 2003 Dec; 46(26):5606-18. PubMed ID: 14667215
[TBL] [Abstract][Full Text] [Related]
7. A bioactive somatostatin analog without a type II' beta-turn: synthesis and conformational analysis in solution.
Jiang S; Gazal S; Gelerman G; Ziv O; Karpov O; Litman P; Bracha M; Afargan M; Gilon C; Goodman M
J Pept Sci; 2001 Oct; 7(10):521-8. PubMed ID: 11695647
[TBL] [Abstract][Full Text] [Related]
8. Novel sst(4)-selective somatostatin (SRIF) agonists. 3. Analogues amenable to radiolabeling.
Erchegyi J; Waser B; Schaer JC; Cescato R; Brazeau JF; Rivier J; Reubi JC
J Med Chem; 2003 Dec; 46(26):5597-605. PubMed ID: 14667214
[TBL] [Abstract][Full Text] [Related]
9. Novel sst(4)-selective somatostatin (SRIF) agonists. 1. Lead identification using a betide scan.
Rivier J; Erchegyi J; Hoeger C; Miller C; Low W; Wenger S; Waser B; Schaer JC; Reubi JC
J Med Chem; 2003 Dec; 46(26):5579-86. PubMed ID: 14667212
[TBL] [Abstract][Full Text] [Related]
10. Common structural features for cytoprotection activities of somatostatin, antamanide and related peptides.
Kessler H; Gehrke M; Haupt A; Klein M; Müller A; Wagner K
Klin Wochenschr; 1986; 64 Suppl 7():74-8. PubMed ID: 2882054
[No Abstract] [Full Text] [Related]
11. Novel sst(4)-selective somatostatin (SRIF) agonists. 2. Analogues with beta-methyl-3-(2-naphthyl)alanine substitutions at position 8.
Erchegyi J; Penke B; Simon L; Michaelson S; Wenger S; Waser B; Cescato R; Schaer JC; Reubi JC; Rivier J
J Med Chem; 2003 Dec; 46(26):5587-96. PubMed ID: 14667213
[TBL] [Abstract][Full Text] [Related]
12. Conformational mimicry: synthesis and solution conformation of a cyclic somatostatin hexapeptide containing a tetrazole cis amide bond surrogate.
Beusen DD; Zabrocki J; Slomczynska U; Head RD; Kao JL; Marshall GR
Biopolymers; 1995 Aug; 36(2):181-200. PubMed ID: 7492745
[TBL] [Abstract][Full Text] [Related]
13. Conformational studies of cyclic enkephalin analogues with L- or D-proline in position 3.
Malicka J; Groth M; Czaplewski C; Wiczk W; Liwo A
Biopolymers; 2002 Apr; 63(4):217-31. PubMed ID: 11807749
[TBL] [Abstract][Full Text] [Related]
14. Cyclic peptides. XIX. Synthesis, conformation, and biological activity of cyclo(-Pro-Val-Pro-Val-) with L-L-L-L and L-D-L-D sequences.
Ueda T; Sada I; Kato T; Izumiya N
Int J Pept Protein Res; 1985 May; 25(5):475-80. PubMed ID: 4019028
[TBL] [Abstract][Full Text] [Related]
15. De novo design, synthesis, and pharmacology of alpha-melanocyte stimulating hormone analogues derived from somatostatin by a hybrid approach.
Han G; Haskell-Luevano C; Kendall L; Bonner G; Hadley ME; Cone RD; Hruby VJ
J Med Chem; 2004 Mar; 47(6):1514-26. PubMed ID: 14998337
[TBL] [Abstract][Full Text] [Related]
16. Backbone modifications in somatostatin analogues: relation between conformation and activity.
Van Binst G; Tourwé D
Pept Res; 1992; 5(1):8-13. PubMed ID: 1352471
[TBL] [Abstract][Full Text] [Related]
17. Conformational mobility in cyclic oligopeptides.
Kopple KD; Bean JW; Bhandary KK; Briand J; D'Ambrosio CA; Peishoff CE
Biopolymers; 1993 Jul; 33(7):1093-9. PubMed ID: 8102073
[TBL] [Abstract][Full Text] [Related]
18. Cyclic peptide analysis of the biologically active loop region in the laminin alpha3 chain LG4 module demonstrates the importance of peptide conformation on biological activity.
Kato-Takagaki K; Suzuki N; Yokoyama F; Takaki S; Umezawa K; Higo J; Mochizuki M; Kikkawa Y; Oishi S; Utani A; Nomizu M
Biochemistry; 2007 Feb; 46(7):1952-60. PubMed ID: 17261031
[TBL] [Abstract][Full Text] [Related]
19. Two unprecedented natural Aib-peptides with the (Xaa-Yaa-Aib-Pro) motif and an unusual C-terminus: structures, membrane-modifying and antibacterial properties of pseudokonins KL III and KL VI from the fungus Trichoderma pseudokoningii.
Rebuffat S; Goulard C; Hlimi S; Bodo B
J Pept Sci; 2000 Oct; 6(10):519-33. PubMed ID: 11071266
[TBL] [Abstract][Full Text] [Related]
20. Structure-activity relationships of cyclic peptide-based chemokine receptor CXCR4 antagonists: disclosing the importance of side-chain and backbone functionalities.
Ueda S; Oishi S; Wang ZX; Araki T; Tamamura H; Cluzeau J; Ohno H; Kusano S; Nakashima H; Trent JO; Peiper SC; Fujii N
J Med Chem; 2007 Jan; 50(2):192-8. PubMed ID: 17228861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
